FDAsafety guidance66% confidence
Hubei Gedian Humanwell Pharmaceutical Co., Ltd. - 725591 - 06/03/2026
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Sun Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Dermatology · Acne
- Sub-indication
- General
Related signal: FDA Accepts Supplement for ABSORICA LD by Sun Pharma